Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine

Clinical trial NCT05249816 · COMPLETED

Trial details

NCT number: NCT05249816
Sponsor: Cogna Technology Solutions LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Start date: 2022-03-18
Primary completion: 2023-05-04
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.